MYRIAD GENETICS, INC.
Income Statement
| Line Item | FY2009 |
|---|---|
| Revenue | $326.5M |
| Cost of Revenue | $43.3M |
| Gross Profit | $283.3M |
| Gross Margin | 86.7% |
| Operating Expenses | |
| Research & Development | $17.9M |
| SG&A Expense | $138.9M |
| Operating Income | $126.5M |
| Operating Margin | 38.7% |
| Interest Expense | — |
| Pretax Income | $136.4M |
| Income Tax Expense | $193.0K |
| Net Income | $84.6M |
| Net Margin | 25.9% |
| EPS (Basic) | $0.91 |
| EPS (Diluted) | $0.86 |
| Shares Outstanding (Basic) | 93.5M |
| Shares Outstanding (Diluted) | 98.6M |
| Dividends Per Share | — |